WHO ICTRP trial

Investigation of the AcrySof® IQ PanOptix* Presbyopia Correcting IOL Model…

NL-OMON44109 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting

Key facts

Trial ID NL-OMON44109
Public title Investigation of the AcrySof® IQ PanOptix* Presbyopia Correcting IOL Model TFNT00
Scientific title Investigation of the AcrySof® IQ PanOptix* Presbyopia Correcting IOL Model TFNT00 - Investigation of the AcrySof® IQ PanOptix* IOL Model TFNT00
Primary sponsor Alcon Laboratories
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Recruitment status Not Recruiting
Study type Interventional
Phase 4
Countries The Netherlands
Conditions Presbyopia;10047518;Presbyopia
Interventions Eye surgery with removal of the original lens and replacement by an ibntraocular lens. ;PanOptix;Presbyopia
Registration date Apr 1, 2016
Target size 10
Secondary IDs NCT02529488;NL55425.068.15
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations